Danielle P. Porter, PhD

Sr. Director
Gilead Sciences Inc
Foster City, California, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 789 - Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir

  Thursday, October 20, 2022
  4:15 PM – 4:30 PM US ET